Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Importance of minimal residual viremia for relapse prediction in patients with chronic hepatitis C genotype 1 infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Dec 2011

Wiegand Johannes, Neumann Konrad, Böhm Stephan, Weich Viola, Teuber Gerlinde, Klinker Hartwig, Möller Bernd, Rasenack Jens, Hinrichsen Holger, Gerlach Tilman, Spengler Ulrich, Buggisch Peter, Sarrazin Christoph, Berg Thomas

Abstract excerpt

This study demonstrates that a more precise prediction of the individual relapse risk in chronic hepatitis C virus genotype 1 infection can be obtained by kinetics of minimal residual viremia at weeks 4, 8, and 12 in combination with levels of baseline viremia. These data may also help to further individualize new protease inhibitor-based triple therapy regimens.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis C, Chronic
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon alpha-2

Share to Polyethylene Glycols

Share to Recurrence

Share to Ribavirin

Share to Viral Load

Share to Viremia

Source

Identifiers

PMID: 22021919
DOI: 10.1093/cid/cir670

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Importance of minimal residual viremia for relapse prediction in patients with chronic hepatitis C genotype 1 infection.PMID 22021919Read ↗

Prediction of minimal residual viremia in HCV type 1 infected patients receiving interferon-based therapy.Semantic proximity Read ↗

Interferon-alpha plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers.Semantic proximity Read ↗

Identifying HCV genotype 1 patients at risk of relapse.Semantic proximity Read ↗

Characterization of nonrapid virologic response patients infected with HCV genotype 1 who may relapse after standard therapy with peginterferon plus ribavirin.Semantic proximity Read ↗

Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients.Semantic proximity Read ↗

Viral kinetics during the first weeks of pegylated interferon and ribavirin treatment can identify patients at risk of relapse after its discontinuation: new strategies for such patients?Semantic proximity Read ↗

Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients.Semantic proximity Read ↗

Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection.Semantic proximity Read ↗

Risk factors for relapse in chronic hepatitis C patients who have achieved end of treatment response.Semantic proximity Read ↗

Alkaline phosphatase predicts relapse in chronic hepatitis C patients with end-of-treatment response.Semantic proximity Read ↗

Optimizing outcomes in patients with hepatitis C virus genotype 1 or 4.Semantic proximity Read ↗

Early Viral Response Predicts the Efficacy of Antiviral Triple Therapy with Simeprevir, Peg-Interferon and Ribavirin in Patients Infected with Hepatitis C Virus Genotype 1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.